STOCK TITAN

Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

(Moderate)
(Neutral)
Tags

Precision Optics (Nasdaq: POCI) will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, held virtually on Tuesday, August 18, 2026. The company’s presentation is scheduled for 2:30 p.m. ET that day.

The webcast can be accessed via the summit home page at https://lythampartners.com/cts2026/ or directly at https://lythampartners.com/cts2026/poci, with a replay available through the same links. Founded in 1982, Precision Optics designs and manufactures advanced micro-optics, 3D imaging and digital imaging products for healthcare and defense/aerospace markets.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

Two prior conference-related notices recorded -0.53% and -1.18% 24-hour reactions. This platform his...
Analysis

Two prior conference-related notices recorded -0.53% and -1.18% 24-hour reactions. This platform history places the current investor-summit participation alongside a mixed event record, with substantive operating disclosures remaining the key comparison point.

Key Figures

Presentation Date: August 18, 2026 Webcast Time: 2:30 p.m. ET Company Founded: 1982
3 metrics
Presentation Date August 18, 2026 Lytham Partners 2026 Consumer & Technology Investor Summit
Webcast Time 2:30 p.m. ET August 18, 2026 presentation
Company Founded 1982 Precision Optics Corporation history

Historical Context

5 past events · Latest: Jun 09 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 09 Investor conference Neutral -0.5% Conference presentation announcement preceded a negative 24-hour price reaction.
May 18 Investor conference Neutral -1.2% Lytham Partners participation announcement preceded a negative 24-hour price reaction.
May 13 Earnings report Positive +3.9% Q3 fiscal 2026 results included higher revenue and raised full-year guidance.
May 06 Earnings call schedule Neutral +0.8% The company scheduled its Q3 fiscal 2026 results release and conference call.
May 05 Production order Positive +8.8% Precision Optics received a $3.5 million follow-on ophthalmic production order.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Conference-related announcements were followed by negative 24-hour reactions in two recent cases, while earnings and order news had positive reactions.

Key Terms

micro-optics, 3d imaging, 3d endoscopy systems
3 terms
micro-optics technical
"leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies"
Tiny optical components and systems whose critical features are measured in micrometres—such as miniature lenses, prisms, gratings and mirrors—designed to shape, split or focus light inside small devices. Think of them as the tiny camera or eyeglass parts built at chip scale; they matter to investors because they enable miniaturized sensors and displays, affect manufacturing cost and scalability, and influence performance in markets like smartphones, medical devices, automotive sensors and augmented-reality hardware.
3d imaging technical
"proprietary micro-optics, 3D imaging and digital imaging technologies"
Three-dimensional imaging is a set of medical technologies that create a lifelike, volumetric view of organs or structures inside the body instead of a flat picture, like turning a paper map into a small model you can rotate. Investors care because these systems often command higher prices, open new markets for devices and software, and can change clinical adoption, regulatory review and reimbursement — all of which affect revenue and growth potential.
3d endoscopy systems medical
"as well as 3D endoscopy systems to support the rapid proliferation"
3D endoscopy systems are medical imaging devices used during minimally invasive surgeries that produce three-dimensional views of internal organs by combining stereo cameras, optics, lighting, and software to show depth and spatial detail. They matter to investors because improved visualization can change surgical outcomes, procedure times, equipment replacement cycles, training needs, and regulatory requirements, all of which influence hospital buying decisions, recurring revenue streams, and a medical-device maker's growth and profitability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LITTLETON, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026.

The webcast will take place at 2:30 p.m. ET on Tuesday, August 18, 2026. The webcast can be accessed by visiting the summit home page at https://lythampartners.com/cts2026/ or directly at https://lythampartners.com/cts2026/poci. A replay will also be available through the same links.

About Precision Optics Corporation

Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements

This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Company Contact:

PRECISION OPTICS CORPORATION
550 King Street, Building A, Suite 100
Littleton, MA 01460
Telephone: 978-630-1800

Investor Contact:

LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com


FAQ

When will Precision Optics (NASDAQ: POCI) present at the Lytham Partners 2026 Consumer & Technology Investor Summit?

Precision Optics will present via webcast at the Lytham Partners 2026 Consumer & Technology Investor Summit on Tuesday, August 18, 2026, at 2:30 p.m. ET. According to the company, the event is fully virtual and accessible online to investors.

How can investors access the Precision Optics (POCI) webcast for the August 18, 2026 Lytham Partners Summit?

Investors can access the Precision Optics webcast by visiting https://lythampartners.com/cts2026/ or directly at https://lythampartners.com/cts2026/poci. According to Precision Optics, a replay of the presentation will also be available through these same links after the live event.

Will there be a replay of the Precision Optics (POCI) presentation from the 2026 Lytham Partners Investor Summit?

Yes, a replay of Precision Optics’ webcast presentation will be available through the same links used for the live event. According to the company, investors can revisit the session at https://lythampartners.com/cts2026/ and https://lythampartners.com/cts2026/poci after August 18, 2026.

What does Precision Optics (NASDAQ: POCI) do in the medical and defense/aerospace markets?

Precision Optics designs and manufactures advanced optical instruments using proprietary micro-optics, 3D imaging and digital imaging technologies. According to the company, it serves healthcare and defense/aerospace customers from new product concept through mass manufacture, including minimally invasive surgery imaging systems and specialized defense optical solutions.

How is Precision Optics (POCI) positioned in minimally invasive surgery and 3D endoscopy markets?

Precision Optics focuses on enabling next-generation medical devices that require smaller, enhanced imaging systems for minimally invasive surgery and 3D endoscopy. According to the company, its technologies support the growing use of surgical robotic systems and supply complex endocouplers and specialized endoscopes to top-tier medical device firms.

How can investors contact Precision Optics (POCI) or its investor relations representative?

Investors can contact Precision Optics at 550 King Street, Building A, Suite 100, Littleton, MA 01460, telephone 978-630-1800. According to the company, investor relations are handled by Lytham Partners’ Robert Blum at 602-889-9700 or via email at poci@lythampartners.com.